Driven by purpose and powered by science, Dr Charlotte Maserumule is shaping the future of Africa’s health innovation landscape. With a PhD in Medicine from the University of Cambridge, she leads biotech innovation and commercialisation at Market Access Africa, where she develops strategies that accelerate the uptake of diagnostics, vaccines, and other health technologies across the continent. Her work sits at the intersection of science, innovation, and impact — guiding the translation of cutting-edge research into life-saving products. Previously, chief scientist at Mintek’s Health Platform and Nanotechnology Innovation Centre, Charlotte has contributed to the development of pioneering diagnostic tools, patented technologies, and market-ready products now under review by the WHO for prequalification. Recognised among Africa’s top scientific minds, she has received numerous honours, including the South African Women in Science Distinguished Young Woman Researcher Award (2024) and the 2025 Sowetan SMag Woman of the Year in Health and Education title. These recognitions and awards are a testament to her exceptional contributions to the field. Beyond her technical achievements, Dr Charlotte is a passionate mentor, empowering young African innovators to develop sustainable and inclusive health solutions. For her, science is personal — shaped by early loss and a lifelong curiosity about how disease can be defeated. “Purpose and impact often emerge from pain,” she reflects. “Resilience, compassion, and curiosity — that’s where real innovation begins.”
QUALIFICATIONS
- Doctor of Philosophy (PhD) in Medicine, University of Cambridge
- Master of Science (MSc) in Medicine, University of Cape Town – specialising in Molecular Medicine
- Bachelor of Science (BSc) Honours in Medical Cell Biology, University of the Witwatersrand
- Bachelor of Science (BSc) in Medical Sciences, University of Pretoria
ACHIEVEMENTS
I am grateful and proud to lead the biotech innovation and commercialisation efforts at Market Access Africa, where I drive strategies that strengthen Africa’s health biotech ecosystem and improve public health outcomes. I have previously contributed to pioneering biomarker discovery, rapid diagnostic test development, and the manufacturing and commercialisation of health products. My work has led to a patent, peer-reviewed publications (research articles and book chapters), medical device prototypes, and a market-ready product currently undergoing World Health Organisation (WHO) prequalification evaluation. Previously, as chief scientist at Mintek’s Health Platform and Nanotechnology Innovation Centre, I advanced innovative diagnostic technologies critical to disease detection and management. I also served as a consulting principal scientist at Hutano Diagnostics, a biotech start-up based at the University of Oxford’s BioEscalator, where I helped develop a working prototype for a critical diagnostic tool with significant potential impact in global health. Among my most notable achievements, awards and recognitions over the years are the 2014 Cambridge Commonwealth Trust Scholarship for my PhD studies, the 2018 Biotech Fundi Young Researcher Award, the 2024 South African Women in Science Distinguished Young Woman Researcher Award (Transition towards an Innovation Economy category), and the 2025 Sowetan SMag Woman of the Year in Health and Education recognition. Beyond my scientific achievements, I am deeply committed to nurturing the next generation of African health biotech innovators and leaders, empowering them to develop impactful solutions that reduce health inequalities across the continent.